Testing a new tool for naming and identifying unique things
Part of Brain & nervous system clinical trials.
This study tests a new tool called the Monument Test, which checks how well people can name and recognize famous landmarks or unique items. It may help assess memory and thinking skills in adults with or without Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You either have a diagnosis of Alzheimer's disease (with a memory test score between 18 and 26) or you are a healthy volunteer with good memory
- You can speak and understand French well
- You have no major hearing or vision problems
- You are not taking strong psychiatric medications (like neuroleptics)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study adapts the Mini-Mental State Exam (MMSE), a short test of memory and thinking, to be more accurate for people living in Reunion Island. If you are 60–89 and either have a cognitive disorder or are a healthy volunteer, you may help improve dementia screening.
This study looks at how people with Alzheimer's disease understand directions and find their way around. By comparing patients, healthy older adults, and caregivers, researchers hope to learn more about spatial orientation problems in Alzheimer’s and find better ways to support patients.
This study looks at how well people can pay attention and remember information during testing. It may help researchers understand “source monitoring” (how you tell where a thought or memory came from) in people with certain neuropsychiatric conditions.
This study evaluates a test battery (ExéSem) that helps doctors understand how executive functions (like planning and problem-solving) contribute to language and meaning disorders. Participants will complete cognitive tasks, and the results may help improve diagnosis and care for people with certain memory or language conditions.
This trial studies whether automated analysis of your voice and speech can help detect early signs of Alzheimer’s disease and mood (affective) problems. It may help identify changes sooner, using voice and questionnaire information from people who are cognitively healthy to very mildly affected.
This study is testing a new way to measure memory and thinking in people with Alzheimer's disease. Taking part could help researchers find better tools to track the disease and might help you understand your own condition better.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.